- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Beyond CAR-T: The rise of CAR-NK cell therapy in asthma immunotherapy ; volume:22 ; number:1 ; day:5 ; month:8 ; year:2024 ; pages:1-43 ; date:12.2024
Journal of translational medicine ; 22, Heft 1 (5.8.2024), 1-43, 12.2024
- Creator
-
Mohammad Taheri, Mohadeseh
Javan, Fatemeh
Poudineh, Mohadeseh
Athari, Seyed Shamseddin
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12967-024-05534-8
- URN
-
urn:nbn:de:101:1-2410252103589.641944886114
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:33 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Mohammad Taheri, Mohadeseh
- Javan, Fatemeh
- Poudineh, Mohadeseh
- Athari, Seyed Shamseddin
- SpringerLink (Online service)
Other Objects (12)
CAR-T and CAR-NK as cellular cancer immunotherapy for solid tumors
CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy
Nanobody-based CAR-T cells for cancer immunotherapy
Breakthrough of solid tumor treatment: CAR-NK immunotherapy
Adoptive cellular immunotherapy for solid neoplasms beyond CAR-T
Current status and perspective of CAR-T and CAR-NK cell therapy trials in Germany
Engineering CAR-T cells
Repurposing anti-mesothelin CAR-NK immunotherapy against colorectal cancer
Visualizing CAR-T cell Immunotherapy Using 3 Tesla Fluorine-19 MRI
CAR-NK cells for cancer immunotherapy: from bench to bedside
Cost of implementing CAR-T activity and managing CAR-T patients: an exploratory study
Hurdles of CAR-T cell-based cancer immunotherapy directed against solid tumors
CAR-T and CAR-NK as cellular cancer immunotherapy for solid tumors
CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy
Nanobody-based CAR-T cells for cancer immunotherapy
Breakthrough of solid tumor treatment: CAR-NK immunotherapy
Adoptive cellular immunotherapy for solid neoplasms beyond CAR-T
Current status and perspective of CAR-T and CAR-NK cell therapy trials in Germany
Engineering CAR-T cells
Repurposing anti-mesothelin CAR-NK immunotherapy against colorectal cancer
Visualizing CAR-T cell Immunotherapy Using 3 Tesla Fluorine-19 MRI
CAR-NK cells for cancer immunotherapy: from bench to bedside
Cost of implementing CAR-T activity and managing CAR-T patients: an exploratory study
Hurdles of CAR-T cell-based cancer immunotherapy directed against solid tumors
CAR-T and CAR-NK as cellular cancer immunotherapy for solid tumors
CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy
Nanobody-based CAR-T cells for cancer immunotherapy
Breakthrough of solid tumor treatment: CAR-NK immunotherapy
Adoptive cellular immunotherapy for solid neoplasms beyond CAR-T
Current status and perspective of CAR-T and CAR-NK cell therapy trials in Germany
Engineering CAR-T cells
Repurposing anti-mesothelin CAR-NK immunotherapy against colorectal cancer
Visualizing CAR-T cell Immunotherapy Using 3 Tesla Fluorine-19 MRI
CAR-NK cells for cancer immunotherapy: from bench to bedside
Cost of implementing CAR-T activity and managing CAR-T patients: an exploratory study